Drug Therapy, Combination

"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Therapy with two or more separate preparations given for a combined effect.

Descriptor ID	D004359
MeSH Number(s)	E02.319.310
Concept/Terms	Drug Therapy, Combination Drug Therapy, Combination Combination Chemotherapy Drug Polytherapy Drug Polytherapies Polytherapies, Drug Polytherapy, Drug Therapy, Combination Drug Chemotherapy, Combination Chemotherapies, Combination Combination Chemotherapies Combination Drug Therapy Combination Drug Therapies Drug Therapies, Combination Therapies, Combination Drug Polychemotherapy Polychemotherapy Polychemotherapies

Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Therapy, Combination [E02.319.310]

Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".

Drug Therapy, Combination
Antineoplastic Combined Chemotherapy Protocols
Antiretroviral Therapy, Highly Active

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.

Bar chart showing 366 publications over 31 distinct years, with a maximum of 22 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	3	3
1996	0	2	2
1997	2	4	6
1998	2	5	7
1999	0	3	3
2000	0	6	6
2001	0	8	8
2002	0	9	9
2003	2	15	17
2004	0	12	12
2005	0	11	11
2006	1	14	15
2007	0	13	13
2008	1	15	16
2009	0	19	19
2010	1	20	21
2011	1	19	20
2012	1	16	17
2013	0	22	22
2014	0	15	15
2015	1	18	19
2016	0	14	14
2017	1	15	16
2018	0	17	17
2019	0	18	18
2020	1	13	14
2021	0	7	7
2022	0	6	6
2023	0	4	4
2024	3	5	8
2025	0	1	1

Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.

Singh D, Martinez FJ, Hurst JR, Han MK, Gale CP, Fredriksson M, Kisielewicz D, Mushunje A, Movitz C, Ojili N, Parikh H, Arya N, Bowen K, Patel M. Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS). Am J Respir Crit Care Med. 2025 Feb; 211(2):205-214.

View in: PubMed
Harrold LR, Bingham CO, Pope JE, O'Brien J, Moore PC, Roberts-Toler C, Yu M, Sweet LL, Shelbaya A, Masri KR. Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry. Clin Rheumatol. 2025 Feb; 44(2):635-648.

View in: PubMed
Chaudhry IB, Husain MO, Khoso AB, Kiran T, Husain MI, Qurashi I, Rahman RU, Mehmood N, Drake R, Husain N, Deakin B. Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 ? 2 factorial design, randomised controlled comparison with simvastatin. J Psychopharmacol. 2024 Sep; 38(9):818-826.

View in: PubMed
Patidar KR, Tu W, Cotter TG, Simonetto DA, Asgharpour A, Jan MY, Tang Q, Yu Y, Li Y, Taiwo M, Thevkar Nagesh P, Dasarathy S, Kamath PS, McClain CJ, Chalasani N, Szabo G, Bataller R, Mitchell M, Mehal WZ, Nagy LE, Shah VH, Gawrieh S, Sanyal AJ. Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology. 2025 Apr 01; 81(4):1256-1268.

View in: PubMed
Andrews P, Vega JN, Szymkowicz SM, Newhouse P, Tyndale R, Elson D, Kang H, Siddiqi S, Tyner EB, Mather K, Gunning FM, Taylor WD. Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. J Affect Disord. 2024 Oct 01; 362:416-424.

View in: PubMed
Cintr?n Pastrana MA, Irizarry Flores JC, Rothschild AJ. Challenges in the Treatment of Psychotic Bipolar Depression. J Clin Psychopharmacol. 2024 Jul-Aug 01; 44(4):407-412.

View in: PubMed
Kosowsky T, Gonzalez E, Shah AS, Griffith JF. Prolonged hypotony maculopathy following uneventful strabismus surgery. J AAPOS. 2024 Aug; 28(4):103939.

View in: PubMed
Fan EY, Schanzer A, Beck AW, Eagleton MJ, Farber MA, Gasper WJ, Lee WA, Oderich GS, Parodi FE, Schneider DB, Sweet MP, Timaran CH, Simons JP. Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair. J Vasc Surg. 2024 Oct; 80(4):968-978.e3.

View in: PubMed
Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, Wunsch H, Walkey AJ, Bosch NA. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024 05 15; 209(10):1219-1228.

View in: PubMed
Hagmann SHF, Hodle T, Brennan M, Szczerba F, Camelo IY, Beachy J, Horton ER. Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants. Pediatr Infect Dis J. 2024 Feb 01; 43(2):145-148.

View in: PubMed

People

Explore

Similar Concepts

Top Journals